HK1151694A1 - Fused bicyclic pyrimidine compounds as aurora kinase inhibitors - Google Patents
Fused bicyclic pyrimidine compounds as aurora kinase inhibitorsInfo
- Publication number
- HK1151694A1 HK1151694A1 HK11105941.6A HK11105941A HK1151694A1 HK 1151694 A1 HK1151694 A1 HK 1151694A1 HK 11105941 A HK11105941 A HK 11105941A HK 1151694 A1 HK1151694 A1 HK 1151694A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- kinase inhibitors
- fused bicyclic
- aurora kinase
- pyrimidine compounds
- bicyclic pyrimidine
- Prior art date
Links
- 239000003719 aurora kinase inhibitor Substances 0.000 title 1
- -1 bicyclic pyrimidine compounds Chemical class 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/02—Silicon compounds
- C07F7/08—Compounds having one or more C—Si linkages
- C07F7/0803—Compounds with Si-C or Si-Si linkages
- C07F7/081—Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te
- C07F7/0812—Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te comprising a heterocyclic ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US4906308P | 2008-04-30 | 2008-04-30 | |
| PCT/US2009/041382 WO2009134658A2 (en) | 2008-04-30 | 2009-04-22 | Fused bicyclic pyrimidine compounds as aurora kinase inhibitors |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HK1151694A1 true HK1151694A1 (en) | 2012-02-10 |
Family
ID=41255689
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HK11105941.6A HK1151694A1 (en) | 2008-04-30 | 2011-06-13 | Fused bicyclic pyrimidine compounds as aurora kinase inhibitors |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US8138194B2 (no) |
| EP (1) | EP2276346B1 (no) |
| JP (1) | JP5502072B2 (no) |
| KR (1) | KR101667822B1 (no) |
| CN (1) | CN102014627B (no) |
| AU (1) | AU2009241469B2 (no) |
| CA (1) | CA2722220C (no) |
| DK (1) | DK2276346T3 (no) |
| ES (1) | ES2616255T3 (no) |
| HK (1) | HK1151694A1 (no) |
| PL (1) | PL2276346T3 (no) |
| TW (1) | TWI363627B (no) |
| WO (1) | WO2009134658A2 (no) |
Families Citing this family (30)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2013515740A (ja) * | 2009-12-23 | 2013-05-09 | バイオクライスト ファーマシューティカルズ， インコーポレイテッド | Ｊａｎｕｓキナーゼインヒビターとしての複素環式化合物 |
| KR20120124428A (ko) | 2009-12-30 | 2012-11-13 | 아르퀼 인코포레이티드 | 치환된 피롤로-아미노피리미딘 화합물 |
| US8569331B2 (en) | 2010-11-01 | 2013-10-29 | Arqule, Inc. | Substituted benzo[f]lmidazo[1,2-d]pyrido[2,3-b][1,4]diazepine compounds |
| MY169268A (en) * | 2012-03-30 | 2019-03-20 | Rhizen Pharmaceuticals S A | Novel 3,5-disubstituted-3h-imidazo[4,5-b]pyridine and 3,5-disubstitued -3h-[1,2,3]triazolo[4,5-b] pyridine compounds as modulators of c-met protein kinases |
| US20150133426A1 (en) | 2012-05-21 | 2015-05-14 | Bayer Pharma Aktiengesellschaft | Substituted pyrrolopyrimidines |
| US9540392B2 (en) | 2012-05-21 | 2017-01-10 | Bayer Pharma Aktiengesellschaft | Thienopyrimidines |
| CA2873967A1 (en) | 2012-05-21 | 2013-11-28 | Bayer Pharma Aktiengesellschaft | Substituted benzothienopyrimidines |
| AP3902A (en) | 2012-06-29 | 2016-11-17 | Pfizer | Novel 4-(substituted-amino)-7H-pyrrolo[2,3-d]pyrimidines as LRRK2 inhibitors |
| TW201412740A (zh) | 2012-09-20 | 2014-04-01 | Bayer Pharma AG | 經取代之吡咯并嘧啶胺基苯并噻唑酮 |
| CN103664993B (zh) * | 2012-09-25 | 2016-05-25 | 韩冰 | 一类治疗缺血性脑损伤的化合物及其用途 |
| CN103012428A (zh) * | 2013-01-08 | 2013-04-03 | 中国药科大学 | 4-(五元杂环并嘧啶/吡啶取代)氨基-1H-3-吡唑甲酰胺类CDK/Aurora双重抑制剂及其用途 |
| US20160159816A1 (en) | 2013-02-01 | 2016-06-09 | Bayer Pharma Aktiengesellschaft | Substituted thienopyrimidines and pharmaceutical use thereof |
| CA2903925A1 (en) | 2013-03-06 | 2014-09-12 | Bayer Pharma Aktiengesellschaft | Substituted thiazolopyrimidines |
| EP3083618B1 (en) | 2013-12-17 | 2018-02-21 | Pfizer Inc | Novel 3,4-disubstituted-1h-pyrrolo[2,3-b]pyridines and 4,5-disubstituted-7h-pyrrolo[2,3-c]pyridazines as lrrk2 inhibitors |
| AP2016009464A0 (en) | 2014-04-25 | 2016-09-30 | Pfizer | Heteroaromatic compounds and their use as dopamine d1 ligands |
| FR3037956B1 (fr) * | 2015-06-23 | 2017-08-04 | Servier Lab | Nouveaux derives d'acide amine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
| CN105061460B (zh) * | 2015-08-18 | 2017-06-30 | 沈阳药科大学 | 含有硫醚结构的四氢苯并[4,5]噻吩并[2,3‑d]嘧啶类化合物及其应用 |
| CN105061461B (zh) * | 2015-08-18 | 2017-06-30 | 沈阳药科大学 | 含有苄胺结构的四氢苯并[4,5]噻吩并[2,3‑d]嘧啶类化合物及其应用 |
| JP6873980B2 (ja) | 2015-09-14 | 2021-05-19 | ファイザー・インク | ＬＲＲＫ２阻害薬としての新規のイミダゾ［４，５−ｃ］キノリンおよびイミダゾ［４，５−ｃ］［１，５］ナフチリジン誘導体 |
| US9630968B1 (en) | 2015-12-23 | 2017-04-25 | Arqule, Inc. | Tetrahydropyranyl amino-pyrrolopyrimidinone and methods of use thereof |
| FR3046792B1 (fr) * | 2016-01-19 | 2018-02-02 | Les Laboratoires Servier | Nouveaux derives d'ammonium, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
| CN106243124B (zh) * | 2016-07-29 | 2018-03-09 | 湖北民族学院 | 一种噻吩并嘧啶脲类化合物及其制备方法和应用 |
| WO2018039310A1 (en) | 2016-08-24 | 2018-03-01 | Arqule, Inc. | Amino-pyrrolopyrimidinone compounds and methods of use thereof |
| CN106810512B (zh) * | 2017-01-18 | 2019-09-10 | 江苏省中医药研究院 | Idh2突变体抑制剂及其用途 |
| AU2018318692A1 (en) * | 2017-08-15 | 2020-03-12 | AbbVie Deutschland GmbH & Co. KG | Macrocyclic MCL-1 inhibitors and methods of use |
| JP2020531427A (ja) * | 2017-08-15 | 2020-11-05 | アッヴィ・インコーポレイテッド | 大環状ｍｃｌ−１阻害剤及び使用方法 |
| EP3988555A1 (en) | 2017-08-15 | 2022-04-27 | AbbVie Inc. | Macrocyclic mcl-1 inhibitors and methods of use |
| US20220274992A1 (en) * | 2019-08-26 | 2022-09-01 | Chemwerth, Inc. | Substituted (7h-pyrrolo[2,3-d]pyrimidin-4-yl) amino compounds useful as jak 1 inhibitors |
| CN112500421B (zh) * | 2020-12-15 | 2021-08-24 | 河南科技大学第一附属医院 | 一种可用于杀菌消毒的苯并吡喃脲类化合物的制备方法及应用 |
| TW202413367A (zh) * | 2022-08-19 | 2024-04-01 | 財團法人國家衛生研究院 | Ｔａｍ受體抑制劑 |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE4008726A1 (de) * | 1990-03-19 | 1991-09-26 | Basf Ag | Thieno(2,3-d)pyrimidinderivate |
| HU230302B1 (hu) * | 2000-10-20 | 2015-12-28 | Eisai R&D Management Co., Ltd. | Nitrogéntartalmú aromás származékok és ezeket tartalmazó gyógyászati készítmények |
| DE10141212A1 (de) * | 2001-08-22 | 2003-03-06 | Bayer Ag | Neue 4-Aminofuropyrimidine und ihre Verwendung |
| JP2005508904A (ja) | 2001-09-11 | 2005-04-07 | スミスクライン ビーチャム コーポレーション | 血管新生阻害剤としてのフロ−及びチエノピリミジン誘導体 |
| US6814324B2 (en) * | 2002-07-03 | 2004-11-09 | Segway Systems, Llc | Releasably latchable leader block in tape threading apparatus for data storage systems and method therefor |
| US7528121B2 (en) | 2002-12-24 | 2009-05-05 | Astrazeneca Ab | Phosphonooxy quinazoline derivatives and their pharmaceutical use |
| DK1678166T3 (da) | 2003-10-14 | 2009-11-09 | Univ Arizona State | Proteinkinaseinhibitorer |
| US20050153989A1 (en) * | 2004-01-13 | 2005-07-14 | Ambit Biosciences Corporation | Pyrrolopyrimidine derivatives and analogs and their use in the treatment and prevention of diseases |
| KR20050091462A (ko) | 2004-03-12 | 2005-09-15 | 한국과학기술연구원 | 푸로피리미딘 화합물 및 이를 포함하는 ｄｄｒ2 티로신키나아제 활성 저해제 |
| WO2005111039A2 (en) | 2004-05-14 | 2005-11-24 | Millennium Pharmaceuticals, Inc. | Compounds and methods for inhibiting mitotic progression by inhibition of aurora kinase |
| MXPA06015223A (es) | 2004-06-29 | 2007-11-09 | Amgen Inc | Furanopirimidinas. |
| WO2006003440A1 (en) | 2004-07-05 | 2006-01-12 | Astex Therapeutics Limited | 3,4-disubstituted pyrazoles as cyclin dependent kinases (cdk) or aurora kinase or glycogen synthase 3 (gsk-3) inhibitors |
| AU2005290226A1 (en) * | 2004-07-16 | 2006-04-06 | Sunesis Pharmaceuticals, Inc. | Thienopyrimidines useful as Aurora kinase inhibitors |
| CN101160316A (zh) * | 2004-07-16 | 2008-04-09 | 苏内西斯医药公司 | 适合用作aurora激酶抑制剂的噻吩并嘧啶 |
| WO2007013964A1 (en) | 2005-07-22 | 2007-02-01 | Sunesis Pharmaceuticals, Inc. | Pyrazolo pyrimidines useful as aurora kinase inhibitors |
| DE102005037499A1 (de) * | 2005-08-09 | 2007-02-15 | Merck Patent Gmbh | Pyrazolderivate |
| KR20080075837A (ko) * | 2005-10-28 | 2008-08-19 | 아이알엠 엘엘씨 | 단백질 키나제 억제제로서의 화합물 및 조성물 |
| BRPI0620341A2 (pt) | 2005-12-23 | 2011-11-08 | Smithkline Beecham Corparation | azaindóis inibidores de cinases aurora |
-
2009
- 2009-04-22 US US12/428,044 patent/US8138194B2/en active Active
- 2009-04-22 EP EP09739460.5A patent/EP2276346B1/en active Active
- 2009-04-22 AU AU2009241469A patent/AU2009241469B2/en active Active
- 2009-04-22 PL PL09739460T patent/PL2276346T3/pl unknown
- 2009-04-22 DK DK09739460.5T patent/DK2276346T3/en active
- 2009-04-22 WO PCT/US2009/041382 patent/WO2009134658A2/en active Application Filing
- 2009-04-22 JP JP2011507540A patent/JP5502072B2/ja active Active
- 2009-04-22 KR KR1020107025018A patent/KR101667822B1/ko active IP Right Grant
- 2009-04-22 CA CA2722220A patent/CA2722220C/en active Active
- 2009-04-22 CN CN200980115577.4A patent/CN102014627B/zh active Active
- 2009-04-22 ES ES09739460.5T patent/ES2616255T3/es active Active
- 2009-04-29 TW TW098114168A patent/TWI363627B/zh active
-
2011
- 2011-06-13 HK HK11105941.6A patent/HK1151694A1/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| US20090275533A1 (en) | 2009-11-05 |
| EP2276346A4 (en) | 2011-08-24 |
| CN102014627B (zh) | 2014-10-29 |
| TWI363627B (en) | 2012-05-11 |
| EP2276346A2 (en) | 2011-01-26 |
| WO2009134658A2 (en) | 2009-11-05 |
| EP2276346B1 (en) | 2016-11-23 |
| DK2276346T3 (en) | 2017-02-27 |
| ES2616255T3 (es) | 2017-06-12 |
| WO2009134658A3 (en) | 2009-12-30 |
| TW200948365A (en) | 2009-12-01 |
| KR101667822B1 (ko) | 2016-10-19 |
| CA2722220C (en) | 2016-06-07 |
| PL2276346T3 (pl) | 2017-07-31 |
| AU2009241469A1 (en) | 2009-11-05 |
| AU2009241469B2 (en) | 2015-05-07 |
| US8138194B2 (en) | 2012-03-20 |
| CN102014627A (zh) | 2011-04-13 |
| JP2011522789A (ja) | 2011-08-04 |
| JP5502072B2 (ja) | 2014-05-28 |
| KR20100132067A (ko) | 2010-12-16 |
| CA2722220A1 (en) | 2009-11-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1151694A1 (en) | Fused bicyclic pyrimidine compounds as aurora kinase inhibitors | |
| HK1217017A1 (zh) | 作為激酶抑制劑的嘧啶取代的嘌呤化合物 | |
| ZA201101243B (en) | Macrocyclics pyrimidines as aurora kinase inhibitors | |
| HK1162509A1 (en) | Fused bicyclic and tricyclic pyrimidine compounds as tyrosine kinase inhibitors | |
| ZA201100344B (en) | Pyrimidine derivatives as kinase inhibitors | |
| HK1220455A1 (zh) | 嘧啶取代的大環抑制劑 | |
| IL218271A0 (en) | Heterocyclic compounds as janus kinase inhibitors | |
| HK1145496A1 (zh) | 作為蛋白酪氨酸激酶抑制劑的雙環雜環化合物 | |
| HK1145495A1 (zh) | 作為蛋白酪氨酸激酶抑制劑的雙環雜環化合物 | |
| PT2231642E (pt) | Pirimidinas como inibidores de quinase | |
| IL206358A0 (en) | Pyrrolopyrazine kinase inhibitors | |
| IL206818A0 (en) | Pyrrolopyrazine kinase inhibitors | |
| HK1161251A1 (en) | Pyrazine compounds as phosphodiesterase 10 inhibitors | |
| HK1146042A1 (en) | Pyrimidine derivatives as protein kinase inhibitors | |
| EP2331530A4 (en) | CONDENSED MULTICYCLIC COMPOUNDS AS PROTEIN KINASE INHIBITORS | |
| IL209931A0 (en) | Bicyclic heterocycles as mek kinase inhibitors | |
| IL210573A0 (en) | Compounds as kinase inhibitors | |
| IL215119A0 (en) | Substitted fused pyrimidine compounds | |
| HK1166984A1 (en) | Fused pyrimidines as akt inhibitors akt | |
| IL220205A0 (en) | Heterocyclic compounds as janus kinase inhibitors | |
| HK1215434A1 (zh) | 取代的嘧啶衍生物 | |
| HK1156611A1 (en) | Naphthyridininones as aurora kinase inhibitors aurora | |
| ZA201106695B (en) | Substituted fused pyrimidine compounds | |
| ZA201104380B (en) | Pyrazine compounds as phosphodiesterase 10 inhibitors | |
| ZA201004903B (en) | Pyrrolopyrazine kinase inhibitors |